Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma

[1]  G. Kristiansen,et al.  Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis , 2006, Oncogene.

[2]  S. Amar,et al.  Role of Secreted Frizzled-related Protein 1 (SFRP1) in Wound Healing , 2006, Journal of dental research.

[3]  H. Lang,et al.  Impact of Endodontic Treatments on the Rigidity of the Root , 2006, Journal of dental research.

[4]  K. Ohtsubo,et al.  Aberrant Methylation of Secreted Apoptosis-Related Protein 2 (SARP2) in Pure Pancreatic Juice in Diagnosis of Pancreatic Neoplasms , 2006, Pancreas.

[5]  福井 高幸,et al.  Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer , 2006 .

[6]  Florian Fritzsche,et al.  Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies , 2006, BMC Cancer.

[7]  C. Marsit,et al.  Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. , 2005, Cancer research.

[8]  Yusuke Nakamura,et al.  Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. , 2005, Cancer research.

[9]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[10]  M. Esteller.  Aberrant DNA methylation as a cancer-inducing mechanism. , 2005, Annual review of pharmacology and toxicology.

[11]  Irina Klaman,et al.  Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. , 2004, International journal of oncology.

[12]  Y. Taketani,et al.  Methylation‐associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers , 2004, Cancer science.

[13]  Biao He,et al.  Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma , 2004, Oncogene.

[14]  M. Janicot,et al.  Alteration of Frizzled Expression in Renal Cell Carcinoma , 2004, Tumor Biology.

[15]  H. Leffers,et al.  Identification of genes differentially expressed in testes containing carcinoma in situ. , 2004, Molecular human reproduction.

[16]  S. Baylin,et al.  Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer , 2004, Laboratory Investigation.

[17]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[18]  Yvonne Wallis,et al.  The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.

[19]  I. Wieland,et al.  Detection of loss of heterozygosity in theAPC tumor suppressor gene in nonpapillary renal cell carcinoma by microdissection and polymerase chain reaction , 2004, Urological Research.

[20]  J. Rüschoff,et al.  Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique , 2004, Virchows Archiv.

[21]  T. Motoyama,et al.  Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples , 2003, Oncogene.

[22]  G. Dressler.  Tubulogenesis in the developing mammalian kidney. , 2002, Trends in cell biology.

[23]  F. Waldman,et al.  Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. , 2002, Journal of Urology.

[24]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[25]  H. Moch,et al.  Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies , 2001, The Journal of pathology.

[26]  D. Reutzel,et al.  Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization , 2001, Cytogenetic and Genome Research.

[27]  M. Sugita,et al.  Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas , 2001, British Journal of Cancer.

[28]  Yinglu Guo,et al.  Aberrant activity of Wnt/Frizzled signaling pathway in renal cancer cell lines , 2000 .

[29]  S. Paik,et al.  β‐Catenin expression and mutational analysis in renal cell carcinomas , 2000 .

[30]  Y. Kang,et al.  beta-catenin expression and mutational analysis in renal cell carcinomas. , 2000, Pathology international.

[31]  W F Bodmer,et al.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[33]  P. Itäranta,et al.  Wnts as kidney tubule inducing factors. , 1999, The International journal of developmental biology.

[34]  Rainer M. Bohle,et al.  Real-time quantitative RT–PCR after laser-assisted cell picking , 1998, Nature Medicine.

[35]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[36]  M. Mahadevappa,et al.  SARPs: a family of secreted apoptosis-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Varmus,et al.  Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Ito,et al.  Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors. , 1997, Oncology.

[39]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[40]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[41]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.

[42]  M. Hughson,et al.  Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[43]  M. Ortmann,et al.  Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[44]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[45]  R. Stanley,et al.  Papillary renal cell carcinoma. A clinical, radiologic, and pathologic study of 34 cases , 1976, Cancer.